Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fabienne A. R. M. Warmerdam"'
Autor:
Josianne C. H. B. M. Luijten, Linda Brom, Pauline A. J. Vissers, Yes. A. J. van deWouw, Fabienne A. R. M. Warmerdam, Joos Heisterkamp, Stella Mook, Jamal Oulad Hadj, Marc J. vanDet, Liesbeth Timmermans, Maarten C. C. M. Hulshof, Hanneke W. M. vanLaarhoven, Camiel Rosman, Peter D. Siersema, Marjan J. Westerman, Rob H. A. Verhoeven, Grard A. P. Nieuwenhuijzen
Publikováno v:
Cancer Medicine, Vol 11, Iss 12, Pp 2427-2444 (2022)
Abstract Background The probability of undergoing treatment with curative intent according to the hospital of diagnosis varies for esophagogastric cancer in the Netherlands. Little is known about the factors contributing to this variation. This study
Externí odkaz:
https://doaj.org/article/a07d828192da401792ea3de38fd12587
Autor:
Alessandro Leal, Nicole C. T. van Grieken, Doreen N. Palsgrove, Jillian Phallen, Jamie E. Medina, Carolyn Hruban, Mark A. M. Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C. Bruhm, Jenna V. Canzoniero, Jacob Fiksel, Marianne Nordsmark, Fabienne A. R. M. Warmerdam, Henk M. W. Verheul, Dick Johan van Spronsen, Laurens V. Beerepoot, Maud M. Geenen, Johanneke E. A. Portielje, Edwin P. M. Jansen, Johanna van Sandick, Elma Meershoek-Klein Kranenbarg, Hanneke W. M. van Laarhoven, Donald L. van der Peet, Cornelis J. H. van de Velde, Marcel Verheij, Remond Fijneman, Robert B. Scharpf, Gerrit A. Meijer, Annemieke Cats, Victor E. Velculescu
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Identifying patients that will respond to a particular therapy remains a key challenge in precision oncology. Here, in gastric cancer, the authors show that circulating tumour DNA can predict recurrence, provided that the signal from white blood cell
Externí odkaz:
https://doaj.org/article/e873283671f243d3ba192161c80d36a7
Autor:
Hedde D. Biesma, Tanya T. D. Soeratram, Karolina Sikorska, Irene A. Caspers, Hendrik F. van Essen, Jacqueline M. P. Egthuijsen, Aart Mookhoek, Hanneke W. M. van Laarhoven, Mark I. van Berge Henegouwen, Marianne Nordsmark, Donald L. van der Peet, Fabienne A. R. M. Warmerdam, Maud M. Geenen, Olaf J. L. Loosveld, Johanneke E. A. Portielje, Maartje Los, Daniëlle A. M. Heideman, Elma Meershoek-Klein Kranenbarg, Henk H. Hartgrink, Johanna van Sandick, Marcel Verheij, Cornelis J. H. van de Velde, Annemieke Cats, Bauke Ylstra, Nicole C. T. van Grieken
Publikováno v:
Gastric Cancer, 25, 3, pp. 640-651
Biesma, H D, Soeratram, T T D, Sikorska, K, Caspers, I A, van Essen, H F, Egthuijsen, J M P, Mookhoek, A, van Laarhoven, H W M, van Berge Henegouwen, M I, Nordsmark, M, van der Peet, D L, Warmerdam, F A R M, Geenen, M M, Loosveld, O J L, Portielje, J E A, Los, M, Heideman, D A M, Meershoek-Klein Kranenbarg, E, Hartgrink, H H, van Sandick, J, Verheij, M, van de Velde, C J H, Cats, A, Ylstra, B & van Grieken, N C T 2022, ' Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer : a post hoc analysis of the D1/D2 and CRITICS trials ', Gastric Cancer, vol. 25, no. 3, pp. 640-651 . https://doi.org/10.1007/s10120-022-01280-2
Gastric Cancer, 25(3), 640-651. Springer Japan
Gastric Cancer, 25, 640-651. SPRINGER
Gastric Cancer, 25, 640-651
Biesma, H D, Soeratram, T T D, Sikorska, K, Caspers, I A, van Essen, H F, Egthuijsen, J M P, Mookhoek, A, van Laarhoven, H W M, van Berge Henegouwen, M I, Nordsmark, M, van der Peet, D L, Warmerdam, F A R M, Geenen, M M, Loosveld, O J L, Portielje, J E A, Los, M, Heideman, D A M, Meershoek-Klein Kranenbarg, E, Hartgrink, H H, van Sandick, J, Verheij, M, van de Velde, C J H, Cats, A, Ylstra, B & van Grieken, N C T 2022, ' Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer : a post hoc analysis of the D1/D2 and CRITICS trials ', Gastric Cancer, vol. 25, no. 3, pp. 640-651 . https://doi.org/10.1007/s10120-022-01280-2
Gastric Cancer, 25(3), 640-651. Springer Japan
Gastric Cancer, 25, 640-651. SPRINGER
Gastric Cancer, 25, 640-651
Background Epstein–Barr virus positivity (EBV+) and microsatellite instability (MSI-high) are positive prognostic factors for survival in resectable gastric cancer (GC). However, benefit of perioperative treatment in patients with MSI-high tumors r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324d603ba1cdd3ed2ad3cf2ff0c5d83a
https://doi.org/10.1007/s10120-022-01280-2
https://doi.org/10.1007/s10120-022-01280-2
Autor:
Arie J. Verschoor, Fabiënne A. R. M. Warmerdam, Tjalling Bosse, Judith V. M. G. Bovée, Hans Gelderblom
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Pazopanib is an oral tyrosine kinase inhibitor registered for metastatic renal cell carcinoma and soft tissue sarcoma. Liver toxicity is a common side effect for this class of agents. The current opinion is that in case of severe
Externí odkaz:
https://doaj.org/article/10d1511c41524bb0a0bf64a8538f0a19